Gastric or Gastro-Esophgeal Junction Cancer - Avelumab in First-Line Gastric Cancer

The purpose of this study is to demonstrate superiority of treatment with avelumab versus continuation of first-line chemotherapy.

 Learn more at Clinicaltrials.gov NCT0265610

Cancer, Adult Gastrointestinal Cancer